Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,472 public trials 3,315 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

NCT02401815

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Completed

Epidemiological Characteristics of Gastric and Pancreatic Cancers in Latin America

NCT05924789

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Instituto de Oncología San Gerónimo Santa Fe, Santa Fe Province, Argentina
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • HMV - Hospital Moinhos de Vento Porto Alegre, Rio Grande do Sul, Brazil
  • CEPON - Centro de Pesquisas Oncológicas Florianópolis, Santa Catarina, Brazil
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

NCT04805307

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • Affiliated Hospital of Hebei University Baoding, China
View all 32 locations
View Trial Details
Completed

LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04666688

Conditions
Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +32 more
Locations
  • UCLA Los Angeles, California, United States
  • University of Colorado Hospital Denver, Colorado, United States
  • Sarah Cannon Research Institute at Health One Denver, Colorado, United States
  • Sarah Cannon Research Institute, Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

Robotic Low Rectum Anterior Resection

NCT04015804

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • UCL Brussels, Belgium
  • Hôpital Européen Marseille, Bouches Du Rhône, France
  • Institut Paoli Calmettes Marseille, Bouches Du Rhône, France
  • Centre François Baclesse Caen, Calvados, France
View all 19 locations
View Trial Details
Completed

LY3214996 +/- HCQ in Pancreatic Cancer

NCT04386057

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions